Gene Query: SHTN1

Dataset Description Geneva Score
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 44.67
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 44.67
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 39.48
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 39.1
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 32.08
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 29.12
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 28.58
Maturation of human iNSCs 28.47
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 27.62
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 26.56
Epigenomic landscape during organ formation in human early embryos 25.92
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 25.71
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 25.71
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 25.2
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 25.2
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 24.21
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 23.91
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 23.67
Regionally specified human pluripotent stem cell-derived astrocytes 23.25
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 22.47
TCF7L1 knockdown in pancreatic cancer 22.42
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 21.74
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 21.1
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 19.69
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 19.4
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 19.24
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 18.85
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 18.63
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 18.36
PTHrP overexpression in MCF7 cells 17.99
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 17.66
Region-specific Innate Antiviral Responses of the Human Epididymis 16.9
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 16.83
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 16.71
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 15.92
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 15.85
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 15.85
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 15.61
Gene expression changes after LOC550643 silencing 15.61
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 15.52
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 15.42
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 14.93
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 14.92
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 14.9
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 14.81
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 14.68
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 14.44
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 14.31
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 14.18
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 14.12
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 14.11
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 13.68
High-Throughput Kinetic Analysis of Fractional Killing 13.62
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 13.57
NAPRT activation of macrophages 13.54
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 13.48
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 13.44
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 13.35
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 13.3
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 13.04
Effect of Influenza virus infection on lncRNA expression in A549 cells 12.92
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 12.82
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 12.81
Role of CD133 molecule in WNT response and renal repair 12.61
Gene expression changes associated with resistance to tagraxofusp (SL-401) 12.56
RNA-seq of human aneuploid cell lines with Trisomy 21 12.39
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 12.3
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 12.27
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 12.24
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 12.1
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 12.07
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 12.06
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 12.06
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 11.87
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 11.87
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 11.84
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 11.82
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.68
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.68
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 11.67
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.66
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.58
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 11.53
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 11.53
RNA-sequencing of human liver tissue 11.49
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 11.34
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 11.34
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 11.29
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 11.29
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.18
Global analysis of alternative splicing regulated by RBM10 11.03
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 10.89
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 10.87
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 10.87
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 10.87
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 10.86
CD73 knockdown effect in pancreatic cancer cell lines 10.86
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 10.76
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 10.44
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 10.37
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 10.34
Expression data from miR340 overexpressing human A549 cells 10.21
Examining serotonergic neuron differentiation from human iPSCs 10.03
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 10.01
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 9.94
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 9.91
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 9.9
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 9.9
TGF-β promotes genomic instability after loss of RUNX3 9.88
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 9.83
Genome wide expression change by RNF168 knocking down in MCF-7 cells 9.83
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 9.77
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 9.73
Identification of long noncoding RNAs regulated by p53 9.72
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 9.71
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 9.69
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 9.63
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 9.61
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 9.54
SRSF2 mutations impair hematopoiesis and alter exon recognition 9.35
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 9.3
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 9.23
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 9.22
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 9.22
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 9.14
Functional astrocytes differentiated from hiPSCs 9.14
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 9.12
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 9.12
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 9.12
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 9.04
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 9.02
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 9.02
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.97
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.96
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.96
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 8.88
Regulation of highly expressed hCINAP on translatome 8.84
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 8.82
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.82
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.77
Transcriptome-wide response to synthetic chromatin protein PcTF 8.77
Gene expression changes upon drug withdrawal (Mel888 cell line) 8.7
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 8.65
Non-coding regions are the main source of tumor-specific antigens 8.61
Non-coding regions are the main source of tumor-specific antigens [human] 8.61
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 8.6
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 8.54
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 8.48
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 8.47
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 8.47
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 8.43
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 8.43
Gene expression changes caused by KRAS in MCF-10A 8.42
METTL3 promotes translation in human cancer cells 8.42
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 8.41
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 8.39
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 8.35
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 8.35
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.32
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.32
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 8.3
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 8.26
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.2
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 8.19
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 8.18
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.16
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.16
Human cell line and subcutaneous tumor 8.16
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 8.16
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.15
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 8.14
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 8.13
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 8.11
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 8.08
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 8.06
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 7.99
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.98
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.87
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.85
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.84
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 7.83
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 7.81
RNA-Sequencing of HepG2 cells treated with TGFBeta 7.78
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.77
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 7.76
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.7
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.7
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 7.63
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 7.63
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 7.6
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 7.6
The transcriptome effect of overexpressing EZH2 in MCF7 7.59
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.59
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.59
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 7.57
IRF2 is a master regulator of human keratinocyte stem cell fate 7.57
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 7.55
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 7.54
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 7.54
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 7.51
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 7.47
Alagille_Nodder 7.46
RNA Seq of Alagille liver biopsies 7.46
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 7.46
RNA-seq of stable and unstable section of human atherosclerotic plaques 7.43
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.4
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.38
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.38
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.3
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.3
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.3
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.27
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 7.26
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 7.26
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.22
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.22
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 7.2
Transcriptional profile in human S. haematobium infection 7.19
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 7.15
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.13
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 7.11
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 7.11
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 7.08
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.07
RNA-seq analyses of human prostate cancer cells 7.06
RNA-seq of MCF10A cells and CAF 7.02
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 7.01
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 7.0
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 6.99
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 6.99
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 6.98
Effect of from Human Umbilical Vein Endothelial Cells 6.98
Genome-wide Analysis of Chromatin Interactions in Human Cells 6.96
The cohesin release factor WAPL restricts chromatin loop extension. 6.96
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.96
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.92
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 6.88
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 6.85
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 6.85
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 6.83
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 6.8
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 6.8
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 6.79
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 6.79
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 6.77
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.68
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 6.65
Repurposing of promoters and enhancers during mammalian evolution 6.62
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.59
PNET animal model: new insights (II) 6.55
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.54
Transcriptional profiling of LS1034 cells treated with tepoxalin 6.52
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 6.47
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 6.45
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 6.41
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.41
TOP2B disturbed the quality of human oocytes with advanced maternal age 6.35
The effect of PPARG inhibition on human angiomyolipoma cells 6.35
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 6.33
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 6.33
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 6.31
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 6.27
Paxillin regulates genomic networks in prostate cancer [C4-2] 6.26
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 6.24
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 6.22
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.22
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 6.2
Transcriptome wide analysis of classically and alternatively activated macrophages 6.17
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 6.17
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 6.15
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 6.12
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 6.08
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 6.07
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 6.07
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.06
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 6.03
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 5.98
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 5.97
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 5.96
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.96
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 5.95
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.92
circRNA-sequencing 5.85
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.8
Primate-specific gene TMEM14B promotes cortical expansion and folding 5.78
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 5.77
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 5.75
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 5.72
Effect of CHKA knockdown on C4-2 cell transcriptome 5.64
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.6
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.6
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.6
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 5.59
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.59
The Glioma-Infiltrating T Cell Receptor Repertoire 5.58
Knockdown of ADNP in HCT116 colon cancer cells 5.5
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 5.45
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 5.35
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 5.35
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 5.32
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 5.32
iPSC derived motor neuron cultures from C9ORF72 carriers 5.3
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 5.29
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.25
RNA editing in nascent RNA affects pre-mRNA splicing 5.22
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 5.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 5.2
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 5.18
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.17
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 5.15
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.15
RNA sequencing analysis of selumetinib-resistant CRC cells lines 5.12
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 5.01
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.95
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 4.95
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 4.95
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.94
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.9
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.9
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 4.85
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.84
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 4.82
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.73
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 4.7
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 4.68
RNA-seq of cancer cell lines treated with T-025 4.67
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.65
SF3B1 Degron knockdown RNA-seq 4.64
Transcriptome analyses of human pancreatic islets and pseudoislets 4.64
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.57
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 4.57
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.54
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.47
CUREfast: Accelerating research with families 4.46
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 4.4
Gene profiling of human adult and pediatric liver cancer cells 4.27
Interaction between mitoNEET and NAF-1 in cancer cells 4.23
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.23
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 4.22
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 4.17
RNA-Seq of PRMT1 overexpression ECA109 cells 4.05
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 4.0
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 4.0
RNA splicing alteration on glioblastoma and normal neural stem cells 3.88
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.87
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.87
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.84
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.8
RNA seq analysis of human Fetal and adult derived Enterospheres 3.78
Trascriptome of thyroid cancer-induced macrophages 3.76
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 3.75
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.72
RNA-Seq in PWS iPSC-derived neurons 3.63
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.57
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.57
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.45
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.45
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.4
quanTIseq: quantifying immune contexture of human tumors 3.4
Transcriptome analysis of BAP1 knockout and restoration 3.4
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 3.4
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.36
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.32
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.32
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.26
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 3.25
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.23
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.23
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.22
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.2
Gene expression profile in breast cancer cell lines using RNA sequencing 3.14
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 3.1
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.1
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 3.08
SLIGRL-induced gene expression changes in NHEK cells 3.04
Exploring ILF2 regulatory genes by next-generation sequencing 2.99
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 2.98
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.98
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 2.96
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 2.86
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.85
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 2.83
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.75
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.72
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.71
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 2.69
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 2.69
RNAseq of cell lines with knocked in ESR1 mutations 2.61
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.61
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.54
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.51
Gene expression alterations of pancreatic intraepithlial neoplasia 2.48
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.46
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.45
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.45
Generation and functional characterization of MDSC-like cells 2.42
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.4
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.35
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.32
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 2.29
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 2.22
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 2.16
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.15
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.14
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.12
Zika virus directly infects human peripheral neurons and induces cell death 2.06
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.03
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.9
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.89
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.85
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.85
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.81
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.81
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.81
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.72
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.72
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.71
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.7
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.7
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.69
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.66
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.66
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.65
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.63
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.63
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.6
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.54
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.53
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.53
Leucegene: ALL sequencing 1.52
Fibroblasts in cholesteatoma activate osteoclasts. 1.47
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.43
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.43
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.39
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.38
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.38
Ribosomal protein RPL26 is the principal target of UFMylation 1.37
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.37
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.37
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.32
Effect of nuclear IL-33 on gene expression 1.26
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.22
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.18
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.17
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.11
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.11
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.09
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.09
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.08
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.06
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.06
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.05
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.04
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.04
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.02
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.02
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.0
mRNA recovered upon RNF219 IP. [RNA-IP] 0.97
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.96
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.96
The role of the Calcium-Sensing receptor in colorectal cancer 0.95
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.95
Interphase condensins regulate ligand-depedent enhancer activation 0.95
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.84
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.82
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.82
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.81
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.8
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.75
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.74
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.65
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.6
HBEC-shp53-PCHD7 0.56
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.56
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.55
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.52
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.49
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.46
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.45
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.42
Characterization of the Merkel cell carcinoma miRNome 0.41
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.37
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.36
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.36
hNSCs siRNA NOVA2 0.35
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.35
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.31
SNHG5 siRNA knock down in HCT116 cells 0.31
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.27
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.27
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.26
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.24
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.24
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.22
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.18
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.18
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.06
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.06
Transcriptome-wide modulation of splicing by the exon junction complex 0.03
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation